product-limit method of kaplan and meier graphpad prism 8 Search Results


total t4 ria (radioimmunoassay) kit  (IVD Technologies)
90
IVD Technologies total t4 ria (radioimmunoassay) kit
(A and B) Male Abcd1 KO mice were administered chow containing sobetirome or Sob-AM2 from 3–15 weeks of age. The chow was compounded with sobetirome or Sob-AM2 at the estimated concentration required to administer the daily dose shown in the figure. <t>Total</t> <t>T4</t> in serum was measured by radioimmunoassay. (C) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) for four weeks. After 4 weeks, the sobetirome chow was continued and the mice were co-administered daily T4 doses for 10 days by oral gavage. Total T4 in serum was measured by radioimmunoassay. (D) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) or chow containing sobetirome (27 μg/kg/day) and T4 (300 μg/kg/day) from 3–15 weeks of age. Total T4 in serum was measured by radioimmunoassay. All data are represented as box and whisker plots, and the error bars represent minimum and maximum. The number of animals is indicated above each dataset in the figure. Statistical analysis was performed using a one-way ANOVA test with Dunnett’s post-test for multiple comparisons between control and each dose (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001) for A and B and unpaired t-test for D (*P < 0.05).
Total T4 Ria (Radioimmunoassay) Kit, supplied by IVD Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/product-limit+method+of+kaplan+and+meier+graphpad+prism+8/total+t4+ria++radioimmunoassay++kit/pmc07245556-728-2-8
Average 90 stars, based on 1 article reviews
total t4 ria (radioimmunoassay) kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
health  (Dotmatics Limited)
86
Dotmatics Limited health
(A and B) Male Abcd1 KO mice were administered chow containing sobetirome or Sob-AM2 from 3–15 weeks of age. The chow was compounded with sobetirome or Sob-AM2 at the estimated concentration required to administer the daily dose shown in the figure. <t>Total</t> <t>T4</t> in serum was measured by radioimmunoassay. (C) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) for four weeks. After 4 weeks, the sobetirome chow was continued and the mice were co-administered daily T4 doses for 10 days by oral gavage. Total T4 in serum was measured by radioimmunoassay. (D) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) or chow containing sobetirome (27 μg/kg/day) and T4 (300 μg/kg/day) from 3–15 weeks of age. Total T4 in serum was measured by radioimmunoassay. All data are represented as box and whisker plots, and the error bars represent minimum and maximum. The number of animals is indicated above each dataset in the figure. Statistical analysis was performed using a one-way ANOVA test with Dunnett’s post-test for multiple comparisons between control and each dose (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001) for A and B and unpaired t-test for D (*P < 0.05).
Health, supplied by Dotmatics Limited, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/product-limit+method+of+kaplan+and+meier+graphpad+prism+8/health/pm37864786-23-119-133
Average 86 stars, based on 1 article reviews
health - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
sodium hypochlorite solution  (Sinopharm ltd)
90
Sinopharm ltd sodium hypochlorite solution
(A and B) Male Abcd1 KO mice were administered chow containing sobetirome or Sob-AM2 from 3–15 weeks of age. The chow was compounded with sobetirome or Sob-AM2 at the estimated concentration required to administer the daily dose shown in the figure. <t>Total</t> <t>T4</t> in serum was measured by radioimmunoassay. (C) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) for four weeks. After 4 weeks, the sobetirome chow was continued and the mice were co-administered daily T4 doses for 10 days by oral gavage. Total T4 in serum was measured by radioimmunoassay. (D) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) or chow containing sobetirome (27 μg/kg/day) and T4 (300 μg/kg/day) from 3–15 weeks of age. Total T4 in serum was measured by radioimmunoassay. All data are represented as box and whisker plots, and the error bars represent minimum and maximum. The number of animals is indicated above each dataset in the figure. Statistical analysis was performed using a one-way ANOVA test with Dunnett’s post-test for multiple comparisons between control and each dose (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001) for A and B and unpaired t-test for D (*P < 0.05).
Sodium Hypochlorite Solution, supplied by Sinopharm ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/product-limit+method+of+kaplan+and+meier+graphpad+prism+8/sodium+hypochlorite/pm36853717-71-30-33
Average 90 stars, based on 1 article reviews
sodium hypochlorite solution - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
computing n a  (10X Genomics)
86
10X Genomics computing n a
(A and B) Male Abcd1 KO mice were administered chow containing sobetirome or Sob-AM2 from 3–15 weeks of age. The chow was compounded with sobetirome or Sob-AM2 at the estimated concentration required to administer the daily dose shown in the figure. <t>Total</t> <t>T4</t> in serum was measured by radioimmunoassay. (C) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) for four weeks. After 4 weeks, the sobetirome chow was continued and the mice were co-administered daily T4 doses for 10 days by oral gavage. Total T4 in serum was measured by radioimmunoassay. (D) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) or chow containing sobetirome (27 μg/kg/day) and T4 (300 μg/kg/day) from 3–15 weeks of age. Total T4 in serum was measured by radioimmunoassay. All data are represented as box and whisker plots, and the error bars represent minimum and maximum. The number of animals is indicated above each dataset in the figure. Statistical analysis was performed using a one-way ANOVA test with Dunnett’s post-test for multiple comparisons between control and each dose (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001) for A and B and unpaired t-test for D (*P < 0.05).
Computing N A, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/product-limit+method+of+kaplan+and+meier+graphpad+prism+8/a+computing+n/pmc07677180-1150-85-79
Average 86 stars, based on 1 article reviews
computing n a - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
a-cenp-c (guinea pig  (MBL International)
90
MBL International a-cenp-c (guinea pig
(A and B) Male Abcd1 KO mice were administered chow containing sobetirome or Sob-AM2 from 3–15 weeks of age. The chow was compounded with sobetirome or Sob-AM2 at the estimated concentration required to administer the daily dose shown in the figure. <t>Total</t> <t>T4</t> in serum was measured by radioimmunoassay. (C) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) for four weeks. After 4 weeks, the sobetirome chow was continued and the mice were co-administered daily T4 doses for 10 days by oral gavage. Total T4 in serum was measured by radioimmunoassay. (D) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) or chow containing sobetirome (27 μg/kg/day) and T4 (300 μg/kg/day) from 3–15 weeks of age. Total T4 in serum was measured by radioimmunoassay. All data are represented as box and whisker plots, and the error bars represent minimum and maximum. The number of animals is indicated above each dataset in the figure. Statistical analysis was performed using a one-way ANOVA test with Dunnett’s post-test for multiple comparisons between control and each dose (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001) for A and B and unpaired t-test for D (*P < 0.05).
A Cenp C (Guinea Pig, supplied by MBL International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/product-limit+method+of+kaplan+and+meier+graphpad+prism+8/guinea+pig+anti+cenp+c/pmc06883791__pnas__1911880116__sapp-1-31-34
Average 90 stars, based on 1 article reviews
a-cenp-c (guinea pig - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(A and B) Male Abcd1 KO mice were administered chow containing sobetirome or Sob-AM2 from 3–15 weeks of age. The chow was compounded with sobetirome or Sob-AM2 at the estimated concentration required to administer the daily dose shown in the figure. Total T4 in serum was measured by radioimmunoassay. (C) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) for four weeks. After 4 weeks, the sobetirome chow was continued and the mice were co-administered daily T4 doses for 10 days by oral gavage. Total T4 in serum was measured by radioimmunoassay. (D) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) or chow containing sobetirome (27 μg/kg/day) and T4 (300 μg/kg/day) from 3–15 weeks of age. Total T4 in serum was measured by radioimmunoassay. All data are represented as box and whisker plots, and the error bars represent minimum and maximum. The number of animals is indicated above each dataset in the figure. Statistical analysis was performed using a one-way ANOVA test with Dunnett’s post-test for multiple comparisons between control and each dose (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001) for A and B and unpaired t-test for D (*P < 0.05).

Journal: Cell chemical biology

Article Title: Pharmacological complementation remedies an inborn error of lipid metabolism

doi: 10.1016/j.chembiol.2020.02.008

Figure Lengend Snippet: (A and B) Male Abcd1 KO mice were administered chow containing sobetirome or Sob-AM2 from 3–15 weeks of age. The chow was compounded with sobetirome or Sob-AM2 at the estimated concentration required to administer the daily dose shown in the figure. Total T4 in serum was measured by radioimmunoassay. (C) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) for four weeks. After 4 weeks, the sobetirome chow was continued and the mice were co-administered daily T4 doses for 10 days by oral gavage. Total T4 in serum was measured by radioimmunoassay. (D) Male Abcd1 KO mice were administered chow containing sobetirome (27 μg/kg/day) or chow containing sobetirome (27 μg/kg/day) and T4 (300 μg/kg/day) from 3–15 weeks of age. Total T4 in serum was measured by radioimmunoassay. All data are represented as box and whisker plots, and the error bars represent minimum and maximum. The number of animals is indicated above each dataset in the figure. Statistical analysis was performed using a one-way ANOVA test with Dunnett’s post-test for multiple comparisons between control and each dose (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001) for A and B and unpaired t-test for D (*P < 0.05).

Article Snippet: Critical Commercial Assays Total T4 RIA (radioimmunoassay) kit IVD Technologies TT4-1000V-100 Experimental Models: Organisms/Strains Mouse: Abcd1 Tm1Kan :C57BL/6J The Jackson Laboratory #003716 Software and Algorithms EthoVision Noldus https://www.noldus.com/ethovision-xt Analyst 1.6.2 Sciex https://sciex.com/products/software/analyst-software Masshunter Agilent https://www.agilent.com/en/products/software-informatics/mass-spectrometry-software Multiquant Sciex https://sciex.com/products/software/multiquant-software Prism 8 GraphPad https://www.graphpad.com/scientific-software/prism/ Other BetaBasic C8 column ThermoScientific 71405154630 Gamma Counter Packard Cobra II Auto-gamma BeadMill 24 ThermoScientific 15-340-163 Roto-rod IITC Life Science 755 PRP-C18 column Hamilton 79672 BetaBasic C18 column ThermoScientific 71505259270 Open in a separate window KEY RESOURCES TABLE CNS-penetrating thyromimetic prodrug Sob-AM2 is better tolerated in chronic dosing Sob-AM2 is more effective than sobetirome at lowering C26:0 in the CNS VLCFA reduction in the CNS is limited by slow CNS lipid turnover Significance Elevated VLCFAs are linked to disease pathology in X-ALD, and therapeutic strategies for lowering VLCFAs may be beneficial for patients with X-ALD.

Techniques: Concentration Assay, RIA Assay, Whisker Assay, Control

KEY RESOURCES TABLE

Journal: Cell chemical biology

Article Title: Pharmacological complementation remedies an inborn error of lipid metabolism

doi: 10.1016/j.chembiol.2020.02.008

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Critical Commercial Assays Total T4 RIA (radioimmunoassay) kit IVD Technologies TT4-1000V-100 Experimental Models: Organisms/Strains Mouse: Abcd1 Tm1Kan :C57BL/6J The Jackson Laboratory #003716 Software and Algorithms EthoVision Noldus https://www.noldus.com/ethovision-xt Analyst 1.6.2 Sciex https://sciex.com/products/software/analyst-software Masshunter Agilent https://www.agilent.com/en/products/software-informatics/mass-spectrometry-software Multiquant Sciex https://sciex.com/products/software/multiquant-software Prism 8 GraphPad https://www.graphpad.com/scientific-software/prism/ Other BetaBasic C8 column ThermoScientific 71405154630 Gamma Counter Packard Cobra II Auto-gamma BeadMill 24 ThermoScientific 15-340-163 Roto-rod IITC Life Science 755 PRP-C18 column Hamilton 79672 BetaBasic C18 column ThermoScientific 71505259270 Open in a separate window KEY RESOURCES TABLE CNS-penetrating thyromimetic prodrug Sob-AM2 is better tolerated in chronic dosing Sob-AM2 is more effective than sobetirome at lowering C26:0 in the CNS VLCFA reduction in the CNS is limited by slow CNS lipid turnover Significance Elevated VLCFAs are linked to disease pathology in X-ALD, and therapeutic strategies for lowering VLCFAs may be beneficial for patients with X-ALD.

Techniques: RIA Assay, Recombinant, Control, Software, Combined Bisulfite Restriction Analysis Assay